US · Healthcare

Dianthus Therapeutics Inc. (DNTH)

Biotechnology

Dianthus Therapeutics Inc. (DNTH) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-03-24, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for DNTH

P/E ratio

18.00

Dianthus Therapeutics Inc. (DNTH) — FAQ

What is DNTH's P/E ratio?

The price-to-earnings (P/E) ratio for Dianthus Therapeutics Inc. (DNTH) is 18.00 (data as of 2026-03-24).

Does Dianthus Therapeutics Inc. pay a dividend?

Dividend yield is not available in the current snapshot for Dianthus Therapeutics Inc. (DNTH). Check the MyAverix Finance app for the latest dividend data.

What sector is Dianthus Therapeutics Inc. in?

Dianthus Therapeutics Inc. (DNTH) is classified in the Healthcare sector (Biotechnology industry).

What exchange is DNTH listed on?

DNTH is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)